AlloSource received FDA 510(k) clearance to market AceConnex Pre-Sutured Fascia for hip labral reconstruction and augmentation.
AceConnex is intended for use as a component in soft tissue surgical procedures where constructs, including those with allograft tissue, are used for reconstruction, replacement or augmentation of the labrum. The ready-to-use, sterile device will be available in multiple pre-sutured sizes, with trimmable regions that allow for allograft adjustments to match patients’ anatomy. In addition, AceConnex Pre-Sutured Fascia is manufactured to ensure consistency and minimize variability compared to allografts that are manually sutured pre-operatively.
“AceConnex Pre-Sutured Fascia is integral to our mission of providing innovative allografts to advance patient healing,” said Dean Elliott, AlloSource President and CEO. “We are proud to be first to market with an FDA-cleared pre-sutured fascia device to meet the varying needs of hip arthroscopists and patients.”
Source: AlloSource
AlloSource received FDA 510(k) clearance to market AceConnex Pre-Sutured Fascia for hip labral reconstruction and augmentation.
AceConnex is intended for use as a component in soft tissue surgical procedures where constructs, including those with allograft tissue, are used for reconstruction, replacement or augmentation of the labrum. The...
AlloSource received FDA 510(k) clearance to market AceConnex Pre-Sutured Fascia for hip labral reconstruction and augmentation.
AceConnex is intended for use as a component in soft tissue surgical procedures where constructs, including those with allograft tissue, are used for reconstruction, replacement or augmentation of the labrum. The ready-to-use, sterile device will be available in multiple pre-sutured sizes, with trimmable regions that allow for allograft adjustments to match patients’ anatomy. In addition, AceConnex Pre-Sutured Fascia is manufactured to ensure consistency and minimize variability compared to allografts that are manually sutured pre-operatively.
“AceConnex Pre-Sutured Fascia is integral to our mission of providing innovative allografts to advance patient healing,” said Dean Elliott, AlloSource President and CEO. “We are proud to be first to market with an FDA-cleared pre-sutured fascia device to meet the varying needs of hip arthroscopists and patients.”
Source: AlloSource
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.